91��Ƭ

Today, Commissioners from the National Security Commission on Emerging Biotechnology (NSCEB), along with Senator Chris Coons (D-DE) and Representative Sarah McBride (D-DE), visited the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) to see firsthand how government and industry partnerships drive excellence in innovation and workforce development.

Following the recent release of the Biotech Commission’s  on strengthening the biotechnology industry, Commissioners toured NIIMBL’s state-of-the-art facility and participated in a roundtable discussion on the value of a public-private partnership model to accelerate workforce development for a future growth industry like biotechnology.

NIIMBL is a public-private partnership established in 2017 with a focus on accelerating biopharmaceutical innovation, developing and scaling advanced manufacturing technologies, and supporting workforce development through training programs and curriculum development.

The NSCEB’s recent  highlights the need for more private-led, public-supported innovation in biotechnology and emphasizes the need for dedicated workforce development programs to strengthen the domestic biomanufacturing industry.

Delaware is a hub of biotechnology , showing the potential of biotechnology to bring industry, academia, and government together for regional economic development opportunities that can benefit the nation.

“NIIMBL is an important program. We need more emphasis on private-public partnerships like this to make our biotechnology innovation ecosystem and biomanufacturing capabilities the most advanced in the world.” – NSCEB Vice Chair Michelle Rozo

“The bipartisan National Security Commission on Emerging Biotechnology’s new report makes clear that we are dangerously close to the day when China will pass the U.S. in biotech innovation, and partnerships like NIIMBL are crucial to ensuring that we keep our edge in research and manufacturing. We need to continue to empower NIIMBL and support American biotech to guarantee our security, our health, and our prosperity.” – Senator Chris Coons (D-DE)

“Biotechnology is the next frontier for both economic growth and national security, and Delaware is already helping lead the way. Through institutions like NIIMBL, we’re building the workforce, innovation ecosystem, and manufacturing capacity that will ensure the United States not only keeps pace—but sets the pace—for the world.” – Representative Sarah McBride (D-DE)

“The commission’s report highlights the national imperative to adopt a proactive approach to ensure global leadership in biotechnology, and we are grateful to the NSCEB, Senator Coons, and Representative McBride for taking time to learn about NIIMBL’s programs that advance our domestic biopharmaceutical manufacturing base.” –NIIMBL Director, Kelvin Lee